Funded Projects & Grants
Scientific Investment
Driving Innovation
From foundational diagnostics to Digital Animal Twins — a decade of publicly-funded breakthroughs in equine and veterinary biotechnology.
7
FUNDED PROJECTS
€2.4M+
TOTAL ELIGIBLE
€1.5M+
FEDER APPROVED
2011-2025
ACTIVE PERIOD
2025 — Ongoing
CIICOH — Center for Integrative Intelligence for Co‑Creation in One Health
CENTRO2030-FEDER-02231000 · Project nº 21379
Develop exploratory scientific and technological foundations for Digital Animal Twins Sentinels, focusing on respiratory health in dogs, cats, and horses — integrating multi-source clinical, genetic, and environmental data via AI-based predictive models.
Total Eligible
€477,388
FEDER Approved
€368,040
AI Predictive
ModelsDigital Twins
PO_Centro — Low Density Territory
- Structured interoperable multi-source database architecture
- Validated taxonomies for cross-species respiratory health
- Identification of molecular and genetic biomarkers
- Characterisation of respiratory RNA/DNA viruses
- Strengthened R&D capacity in predictive diagnostics
Co-financed by
2019 — 2022
HoTT — Horse Testing Tour
CENTRO2030-FEDER-02231000 · Project nº 21379
Demonstrator stage supporting the first international market entry of complementary first-in-class diagnostic kits for the New Equine Virus (NEV): NEV-CHECK c-ELISA and NEV-CHECK molecular.
Total Eligible
€368,765
FEDER Approved
€235,314
NEV Diagnostics
International Markets
PO_Centro — Portugal
- Pilot production line for NEV-CHECK molecular established
- Real-life validation across Europe, Brazil, and the Middle East
- NEV prevalence data mapping across international cohorts
- International technical support network built
Co-financed by
2015 — 2018
NEV-CHECK & EquiNEVir
Centro-01-0247-FEDER-10991
Validate the rapid diagnostic kit prototype (NEV-CHECK) in an operational environment and generate proof of concept for EquiNEVir as an antiviral therapeutic solution for the HIV-like horse virus (NEV).
Total Eligible
€453,482
FEDER Approved
€285,395
Antiviral Therapeutic
Zoonotic Potential
PO_Centro — Portugal
- Confirmed NEV tropism and cross-species zoonotic potential
- Validated NEV-CHECK c-ELISA diagnostic performance
- Advanced the EquiNEVir therapeutic concept
- Certified pilot manufacturing assembly line established
Co-financed by
2016 — 2018
EquiNEVir — A Cure for Horse AIDS
Centro-01-0247-FEDER-17196
Submission of international PCT patent applications to protect antiviral compositions for NEV and Equine Infectious Anemia Virus (EIAV), expanding the scope of previous proprietary technologies.
Total Eligible
€95,000
FEDER Approved
€47,500
PCT Patents
EIAV Protection
PO_Centro — Portugal
- 2 patent families submitted via international PCT route
- 10 international patent processes in national phases
- Core technological assets secured in equine virology
Co-financed by
2014 — 2015
QREN 38.637 — Generation and Consolidation of a New Diagnostic Test
CENTRO-07-0202-FEDER-038637
Development of an innovative exportable ELISA diagnostic kit using specific capture peptides for the Portuguese variant of Equine Infectious Anemia Virus (AIE-2), undetectable by existing commercial tests.
Total Eligible
€404,525
FEDER Approved
€230,853
ELISA Kit
AIE-2 Detection
PO_Centro — Portugal
- First specific diagnostic kit for the AIE-2 variant
- Molecular and functional virus characterisation complete
- International validation with USA, Brazil, France & Italy
Co-financed by
2013 — 2014
equiG2.0 — E-Commerce Platform for Equine In Vitro Diagnostic Services
CENTRO-07-0203-FEDER-031992-Inovation
Creation of a bilingual online e-commerce platform for the commercialisation and internationalisation of Equigerminal's diagnostic services, including lab equipment acquisition and CE marking.
Total Eligible
€254,228
FEDER Approved
€164,650
E-Commerce
CE Certification
PO_Centro — Portugal
- equiG2.0 transaction and tracking platform launched
- Laboratory quality systems expanded for CE certification
- International marketing campaigns in UK, Germany & Brazil
Co-financed by
2011 — 2013
QREN 18.536 — Diagnostic Test for the Portuguese Variant of Equine Infectious Anemia
CENTRO-07-0202-FEDER-018536
Core research into novel equine lentiviruses, focusing on identification, molecular characterisation, and patenting of the specific microplate ELISA diagnostic kit (VAIE.PTest) for the chronic fatigue viral variant.
Total Eligible
€369,395
FEDER Approved
€187,817
VAIE.PTest
Lentivirus Research
PO_Centro — Portugal
- Serological and genomic bank of Portuguese horses created
- First molecular clone of VAIE generated
- VAIE.PTest assay validated in operational conditions
- Technological foundation laid for all subsequent NEV projects
Co-financed by